|
Originally published In Press as doi:10.1074/jbc.M509450200 on October 24, 2005
J. Biol. Chem., Vol. 280, Issue 50, 41243-41251, December 16, 2005
Liver X Receptor Interferes with SREBP1c-mediated Abcd2 Expression
NOVEL CROSS-TALK IN GENE REGULATION*
Isabelle Weinhofer ,
Markus Kunze ,
Heidelinde Rampler ,
Angie L. Bookout ,
Sonja Forss-Petter , and
Johannes Berger 1
From the
Center for Brain Research, Medical University Vienna, A-1090 Vienna, Austria and the Howard Hughes Medical Institute and Department of Pharmacology, University of Texas, Dallas, Texas 75390
The peroxisomal ATP binding cassette (ABC) transporter adrenoleukodystrophy-related protein, encoded by ABCD2, displays functional redundancy with the X-linked adrenoleukodystrophy-associated protein, making ABCD2 up-regulation of therapeutic value. Cholesterol lowering activates human ABCD2 in cultured cells. To investigate in vivo regulation by sterols, we first characterized a sterol regulatory element (SRE) in the murine Abcd2 promoter that is directly bound by SRE-binding proteins (SREBPs). Intriguingly, this element overlaps with a direct repeat 4, which serves as binding site for liver X receptor (LXR)/retinoid X receptor heterodimers, suggesting novel cross-talk between SREBP and LXR/retinoid X receptor in gene regulation. Using fasting-refeeding and cholesterol loading, SREBP accessibility to the SRE/direct repeat 4 was tested. Results suggest that adipose Abcd2 is induced by SREBP1c, whereas hepatic Abcd2 expression is down-regulated by concurrent activation of LXR and SREBP1c. In cell culture, SREBP1c-mediated Abcd2 induction is counteracted by ligand-activated LXR . Finally, hepatic Abcd2 expression in LXR , -deficient mice is inducible to levels vastly exceeding wild type. Together, we identify LXR as negative modulator of Abcd2, acting through a novel regulatory mechanism involving overlapping SREBP and LXR binding sites.
Received for publication, August 26, 2005
, and in revised form, October 20, 2005.
* This study was supported by a grant from the European Association against Leukodystrophies (ELA, Nancy, France), the Myelin Project, and European Union Project"X-ALD"LSHM-CT2004-502989. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Center for Brain Research, Medical University Vienna, Spitalgasse 4, A-1090 Vienna, Austria. Tel.: 43-1-4277-62812; Fax: 43-1-4277-9628; E-mail: johannes.berger{at}meduniwien.ac.at.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Besnard, S. E. Wert, M. T. Stahlman, A. D. Postle, Y. Xu, M. Ikegami, and J. A. Whitsett
Deletion of Scap in Alveolar Type II Cells Influences Lung Lipid Homeostasis and Identifies a Compensatory Role for Pulmonary Lipofibroblasts
J. Biol. Chem.,
February 6, 2009;
284(6):
4018 - 4030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Besnard, Y. Xu, and J. A. Whitsett
Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression
Am J Physiol Lung Cell Mol Physiol,
December 1, 2007;
293(6):
L1395 - L1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|